* Note, added 19 A ugust 1941. Such dosage lies w ithin th e range com m only em ployed in tests for carcinogenic a c tiv ity b y su b cu taneous injection, b u t is con siderably g reater th a n th e least q u a n tity o f a p o te n t com pound sufficient to produce a high yield of tu m o u rs (see for exam ple Shear an d L eiter 1941). planted tumours mentioned. The use of a reliable propagated tumour also enables closely controlled experiments to be carried out as extensively as may be wished, and thus facilitates the examination of large numbers of compounds on a sufficiently accurate basis.
In an extended investig atio n of th e g ro w th -in h ibitory a c tiv ity of carcino genic com pounds an d related substances, over tw o h u n d red com pounds were tested , including various 5-, 10-a n d 9 :1 0 -su b stitu ted benzanthracenes, dim ethyl d erivatives of an th racen e, nitrogenous analogues of 1 12-benzan thracene, benzphenothiazines a n d dibenzphenothiazines, com pounds related to 3 : 4-benzphenanthrene, dibenzfluorenes, dibenzcarbazoles, dibenz pyrenes, azonaphthalenes a n d re la te d p ro d u cts * n ap h th y lam in es an d naphth aq u in o n es, arsenonap h th alen es, deriv ativ es of trip h en y leth y len e, an d diphenyl d erivatives o f indene, /?-naphthindole an d /7-naphthofuran.
A striking degree of correspondence w as often show n b y th e inh ib ito ry an d carcinogenic a c tiv ity of closely re la te d com pounds (e.g. 5-alkyl b en zan thracenes ; dibenzfluorenes; d ib en zp h en an th ren es; 2 :2 '-azonaphthalene, 2 : 2'-diam ino-1: l'-d in a p h th y l a n d 3 : 4 : 5 : 6-dibenzcarbazole). H ow ever, no inhibito ry a c tiv ity w as observed for ce rta in carcinogenic 10-an d 9:10-su b stitu te d benzanthracenes. O n th e o th e r h an d, in h ib ito ry a c tiv ity was noted in a few com pounds (e.g. 1 :2 '-azonaphthalene) w hich have yielded few or no tu m o u rs in ex haustive tests, a n d in some of a group of sy n th etic oestrogenic com pounds w hich, alth o u g h n o t carcinogenic in th e u sual sense, are nevertheless associated w ith th e in d u ctio n of individual ty p es of tu m o u r u n d er special conditions. The relatio n betw een m olecular s tru c tu re an d in h ib ito ry a c tiv ity depends in general upon an optim al degree of m olecular com plexity an d upon certain m ore specific requirem ents. N evertheless, th e results o b tained w ith d eriv a tives of trip h en y leth y len e suggest th a t in h ib ito ry ac tiv ity m ay still be shown b y com pounds diverging w idely from th e polycyclic stru c tu re an d possessing only a skeletal resem blance.
D im inution of in h ib ito ry effect w ith increased su b stitu e n t size was show n in th e 5-alkyl b enzanthracenes tested , alth o u g h th e sam e relation does n o t necessarily o b tain for o th er positions. The influence of th e n a tu re of th e su b stitu e n t is seen (for exam ple) in th e c o n trast betw een 10-m ethyl-, 10-amino-an d 1 0 -cy an o -l: 2-benzanthracene (inhibitory) an d 10-isopropyl -1 :2 -benzanthracene (inactive). L astly , num erous experim ents indicated th a t solubilization of an active com pound usually entails decrease of activ ity , although certain a p p a re n t exceptions were encountered.
In addition to th e relationship betw een in h ib ito ry ac tiv ity an d carcino genicity, an d th a t betw een b o th biological properties and chem ical stru ctu re, consideration is also given to th e m ode of pro d u ction of th e in h ib ito ry effect. 256 G. M. Badger et al.
I ntroduction
In an investigation of the action of tumour-producing compounds it was found that many carcinogenic hydrocarbons retard the growth of tissues both normal and malignant. Extended investigation showed a statistical association, of high significance, between the biological properties of carcinogenicity and growth-inhibitory power (Haddow 1935 (Haddow , 1938a Haddow and Robinson 1937, 1939; Haddow, Scott and Scott 1937) . It was further suggested that the association is of etiological importance, and tumour induction by these compounds was conceived to take place in two stages: (1) interference with the growth of normal cells and (2) an adaptive cellular reaction-accomplished mainly by dedifferentiation-in virtue of which the altered cells are able to achieve independent multiplication, at an increased rate, in an environment which makes normal growth difficult or impossible for their parent cell. While the new growth characters appear in response to a specific pathological change in the cellular milieu, the cellular changes themselves are permanent: hence they continue to be manifested, indefinitely and without reversion, when the variant cells reach normal tissues either in the same host or artificially in other hosts by transplantation. The direct and collateral evidence supporting this interpretation has been fully reviewed elsewhere (Haddow 1937 (Haddow , 1938 b, c). The principle does not appear to be limited to the mechanism of carcino genesis by chemical compounds, but is probably of wider application; in particular, it was suggested as an explanation of the apparent paradox that X-rays and gamma-rays, as is the case with the carcinogenic hydro carbons, exhibit both tumour-producing and growth-inhibitory activity. In addition to papers confirming the original observation, and alluded to in the references already given, three contributions of more recent date may be mentioned, viz. by Morelli and Dansi (1939) , Dansi, Morelli and Sempronj (1940) , and Davis, Murphy and Emge (1941) .
At an early stage it was recognized that carcinogenicity depends on optimal rather than maximal inhibition. This fact, and a theoretical con sideration to be dealt with in the discussion, held out the prospect of dis covering compounds possessing enhanced inhibitory activity but with carcinogenicity restricted, minimal or even extinguished. The present paper records an extension of this investigation; while it has revealed many new points of interest in relation to the mode of action of carcinogenic agents, progressively more attention has been paid to its inherent possi bilities as a rational approach to the chemotherapy of cancer.
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E xperim ental methods
Assay of the growth-inhibiting activity of individual compounds was made by means of a standard experiment. Two groups each of twelve to fifteen albino rats from a colony maintained for the purpose, carefully selected as to individual weight (c. 100-120 g\), were implanted with the Walker carcinoma 256. The technique of implantation was similar to that previously described. On the following day, animals of the trial series received a single dose, in many cases determined by a preliminary toxicity experiment, of the compound for test (in sterile solution or suspension in arachis oil or in water), by intraperitoneal injection; the control series received an equal volume of the solvent alone. Since the primary object of these experiments was the detection of relatively high activity, and not the determination of absolute presence or absence of inhibitory powrer, doses employed were as a rule only 50 % of those employed in earlier work (Haddow7 and Robinson 1937) .* An estimate of activity w7as obtained by comparing the mean weights of the two series of tumours, after their removal at the end of a suitable interval (in most cases 14 or 15 days). It is believed that the experimental error in the primary data is very small, and certainly as small as can be attained. The significance of any difference between the means was calculated by the t test and also, in certain cases where two or three trial series possessed common controls, by an analysis of variance.
It is a common impression that transplanted tumours are less reliable test objects than are spontaneous tumours, in experiments of this type. While this is probably true for many transplantable tumours, it does not necessarily apply in the case of such tumours as the Walker rat carcinoma 256 or the Crocker mouse sarcoma 180. The former has proved compara tively resistant to cure by X-radiation, and the latter is remarkably refractory to inhibition of any kind. On the other hand, spontaneous adenocarcinomata of the mamma in the mouse w7 ere found in individual cases to be surprisingly sensitive to chemical inhibition (Haddow 1938a) , and, although the range of sensitivity is wide, many instances of regression were observed. Thus, while every prospective chemotherapeutic substance must be tested by its capacity to inhibit spontaneous neoplasms, it need not be assumed that these tumours are more refractory than the trans 258 G. M. Badger et al.
planted tumours mentioned. The use of a reliable propagated tumour also enables closely controlled experiments to be carried out as extensively as may be wished, and thus facilitates the examination of large numbers of compounds on a sufficiently accurate basis.
R esults
{a) Derivatives of 1:2 -benzanthracene (i) 5-alkyl derivatives.
It has been recognized for some considerable time that alkyl substitution in position 5 of the benzanthracene molecule is an important determiner of both carcinogenic and growth-inhibitory properties (Barry, Cook, Haslewood, Hewett, Hieger and Kennaway 1935; Haddow and Robinson 1937) . Table 1 It seemed of interest to ascertain the effect of extension in length of the substituent, and a complete examination was made of seven 5-alkyl derivatives comprising the homologous series 5-methyl-, -ethyl-, -w-propyl-, -w-butyl-, -n-ainyl-, -«-hexyl-and -n-heptyl-1:2-benzanthracene (see Cook and Robinson 1940) . The records given in table 1* show maximal inhi bitory activity in the first member of this series, and the trend of the results * As th e original d a ta on w hich tab les 1-20 are based are too extensive for publica tio n , a copy h as been deposited w ith th e L ib rarian , G eneral L ibrary, B ritish Museum (N atu ral H isto ry ), L ondon, S.W . 7.
indicates very clearly a progressive decline in activity as the number of carbon atoms in the chain is increased to four; subsequent additions pro duced no further diminution which could be measured. Data have been accumulated (see Badger, Cook, Hewett, Kennaway, Kennaway, Martin and Robinson 1940) increases. The correlation coefficient between the two measures is 0-59, but, owing to the small number of observations, is not significant. The data respecting inhibition are derived from two experiments, the com pounds being tested in two groups, of four and three. It is known that both experiments were of good quality, and it seemed justifiable to plot the mean tumour weights as these correspond to the seven substituents. The upward trend of these mean weights is significant, and there is an average increase in tumour weight of 2*95 g. for each carbon atom in the chain. While the significant upward trend of the mean weights is all that can be established, the plotted means suggested that the real relationship is akin to a growth curve, and a logistic curve yields a moderate fit. (Mean tumour weight (W) = 2 + 6.39e-o-596C' where G denotes the num ber of carbon atoms in the side-chain.) This curve gives a significantly better fit than the best horizontal line, and a better fit (although not significantly) than a slanted line.
(ii) 10-and 9 \ \ 0 -substitutedbenzanthracenes. Inhibitory activity has already been reported for the carcinogenic hydrocarbons 9-methyl-, 10-methyl-and 9 :10-dimethyl-1 ^-benzan thracene (Haddow and Robinson 1939) , and tests have now been com pleted for a series of related compounds certain of which possess functional groups conferring, in some cases, solubility in water (Badger and . The details of these experiments are presented in table 2. It is apparent that the introduction of hydroxyl and carboxyl groups is attended by marked loss of growth-inhibitory activity, and in no case was any augmentation observed. Significant inhibition was shown by the carcinogenic compounds 10-amino-and 10-cyano-l: 2-benzanthracene and 1:2-benzanthracene-10-aldehyde (Shear and Leiter 1940) , and was absent in the case of the non-carcinogenic 10-benzyl-, 10-isopropyl-and 9-or 10-acetyl-derivatives. On the other hand, four carcinogenic compounds (10-/?-hydroxyethyl-, 10-acetoxymethyl-, 9 : 10-bishydroxymethyl-and 9-methyl-10-cyano-l : 2-benzanthracene) gave no trace of inhibition. While this is possibly due to the unusually low dosage employed in the individual experiments, certain of these cases constitute real anomalies, and it should be recalled that no inhibitory activity was discovered in the case of 10-hydroxymethyl-1 :2-benzanthracene (Haddow and Robinson 1939) . It may be noted that 1:2-benzanthracene-10-aldehyde was found by Dansi and Vercellone (1939) to be reduced by fermenting yeast to the 10-hydroxymethyl compound. The case of 9 : 10-bisacetoxymethyl-l .2 benzanthracene is of special interest since the dose employed produced a significant stimulation of growth. The mechanism by which such an effect may be caused has been discussed previously (Haddow, Scott and Scott 1937, pp. 498-9).
(b) Dimethyl derivatives of anthracene Since methyl substitution at favourable positions in 1:2-benzanthracene greatly enhances both inhibitory power and carcinogenicity, experiments were carried out with one tetramethyl and five dimethyl derivatives of anthracene, which had itself been found devoid of growth-inhibitory or carcinogenic activity (table 3). Some inhibitory activity was detected with 1:3-dimethylanthracene, although no tumours have been obtained. Also, while carcinogenic activity had been shown by 9 : 10-dimethylanthracene (slow development of three epitheliomata) no inhibition was observed. It is obvious that 1:2:9 : 10-tetramethylanthracene would be of greater interest, on account of its closer relation to a benzanthracene substituted in positions conferring pronounced carcinogenic action. So far this compound remains unknown; three unsuccessful attempts to synthesize it have already been reported (Badger, Cook and Goulden 1940; Fieser and Webber 1940; Badger, Goulden and Warren 1941) . Compounds previously tested for carcinogenic activity, with negative results, include 1-phenyl, 2-phenyl, 9 : 10-dibenzyl and 1:5-dhsopropenylanthracene (Cook J932) . (c) Nitrogenous analogues of 1:2 -benzanthracene, and water-soluble derivatives It had already been found that 1 :2 :5 :6-dibenzacridine possesses inhibitory properties (Haddow 1938a) , and a fuller examination was made to test the influence of methyl substitution in the inactive compound 1 :2-benzacridine, at positions corresponding to 7-, 9-and 5 :7-substitution 264 G. M. Badger et al.
in 1:2-benzanthracene (table 4). It is apparent that such substitution again confers activity, although not to a greater degree than in 1:2-benz anthracene, and possibly less. Little or no activity was demonstrable in water-soluble methosulphates of active compounds, under similar con ditions of test.
'Alizarin Blue' and 'Alizarin Blue AS' represent compounds containing nitrogen in the angular ring: it may be recalled that Sempronj and Morelli (1939) found tumour nodules (? adenocarcinoma) in the kidney in two rats which had been injected with the parent compound /?-anthraquinoline.
(d) Benzphenothiazines and dibenzphenothiazines
A further test of the influence upon activity (1) of changes in the central ring and (2) of alkyl substitution, is provided by the results for 1:2-and 3 :4-benzphenothiazine, three methyl derivatives, and two dibenzpheno thiazines (table 5). 1 :2-Benzphenothiazine manifested slight activity and the 3 :4-isomer none, while the N-methyl derivatives of both compounds proved inhibitory, that from the 1:2 form again appearing the more active. Considerable potency was attained in both 1:2:5 :6-and 3 :4 :5 :6-dibenzphenothiazine.
(e) Compounds related to 3 :4-benzphenanthrene 3 :4-Benzphenanthrene has already been described as producing epitheliomata after a prolonged latent period, and potency is greatly enhanced in the 2-methyl derivative (Barry et al. 1935; Bachmann, Cook, Dansi, de Worms, Haslewood, Hewett and Robinson 1937; Badger et al. 1940) . As regards growth-inhibitory power, a number of experiments showed little or no activity in the parent hydrocarbon, and definite, although not great, activity in 2-methyl-3:4-benzphenanthrene (Haddow and Robinson 1939)-A larger number of derivatives has nowT been tested (see Hewett 1938; Everett and Hewett 1940) in order to study the influence on inhibitory capacity of the position and size of the substituent. Also, experiments have been carried out with 1 :2 :3 :4-dibenzphenanthrene, 1 :2 :5 :6-dibenzphenanthrene, 1 :2-dimethylchrysene and 1 :2 :3 :4-tetramethylphenanthrene (table 6). The effect observed with 2-methyl-3:4-benzphenanthrene did not attain significance, and was considerably exceeded in the case of the 2-ethyl-and 2-isopropyl-compounds. It is of some interest that the early and characteristic histological changes produced by the carcinogenic hydrocarbons as described by Pullinger (1940) were observed by that author to develop only after large doses of 2-methyl-3 :4-benzphenanthrene, and then comparatively slowly.
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Of the tetracyclic aromatic hydrocarbons, chrysene as well as 1:2-benzanthracene and 3 :4-benzphenanthrene is to be regarded as a parent compound of carcinogenic derivatives, and Hewett (1940) has sum marized the development of his work on the influence of substitution in this group. These hydrocarbons are all derivatives of phenanthrene, each substituted in two of the 1-, 2-, 3-and 4-positions. Further substitution of 2:3-benzphenanthrene (i.e. 1:2-benzanthracene) in either or both of the remaining 1-and 4-positions gives rise to highly carcinogenic hydrocarbons (methylcholanthrene, 3 :4-benzpyrene (figure 2, structure IV), 9 : 10-dimethyl-1:2-benzanthracene (structure V)), while further substitution of F i g u r e 2 . S tru ctu res derived from p h en an th ren e, 3 : 4-benzphenanthrene, chrysene an d 1 :2 -benzanthracene (H ew ett 1940) . N um bering indicates relatio n to p h e n a n threne.
3:4-benzphenanthrene in the 1-or the 2-positions (structure I), or in both (structure II), also leads to enhanced activity, as does similar substitution of the 3-and 4-positions of 1 :2-benzphenanthrene giving 1 :2-dimethylchrysene (structure III). In each of these cases the active compound is a phenanthrene derivative substituted in at least three of the positions 1, 2, 3 and 4. Di-substitution in these positions thus leads to little or no activity, while tri-or tetra-substitution confers marked activity. It appeared that the substitution was effective whether represented by two benzene rings (1 :2 :3 :4-dibenzphenanthrene), or by one benzene ring and one or two methyl groups (e.g. 2-methyl-3 :4-benzphenanthrene, 9 :10-dimethyl-1:2-benzanthracene, 1:2-dimethylchrysene), and this con sideration led Hewett to the synthesis of 1 :2 :3 :4-tetramethylphenan-threne (structure VI) (Hewett and Martin 1940) , since it constitutes a link between the carcinogenic derivatives of 1:2-benzanthracene, 3:4-benzphenanthrene and chrysene, and may be regarded as the prototype of all these compounds. Recent tests with this compound are almost complete, and indicate that it possesses slight carcinogenic activity: while no sarcomata appeared in twenty C3H mice each of which had received 5 mg. by injection, an epithelioma was produced in one of ten mice by application of a solution in benzene to the skin (examined at the 398th day). In the present experiments, however, 1 :2 :3 :4-tetramethylphenanthrene showed no inhibitory effect, although pronounced activity was exhibited by 1 :2 :3 :4-dibenzphenanthrene, 1 :2 :5 :6-dibenzphenanthrene and 1:2-dimethylchrysene.
(/) Dibenzfluorenes and related compounds 1 :2 :5 :6-Dibenzfluorene (carcinogenic) and 1 :2 :7 :8-dibenzfluorene had previously been described as manifesting inhibitory activity (Haddow and Robinson 1939) . At that time the latter compound was under test for carcinogenicity, and it has now been reported as active in this respect also (Badger et al. 1940) . Table 7 presents additional results obtained for 1 :2 :3 :4-dibenzfluorene, 3 :4 :5 :6-dibenzfluorene (Martin 1941) and related compounds.
(g) Dibenzcarbazoles
The carcinogenic action of the 3 :4 :5 :6-, 1:2:5 :6-and 1 :2 :7 :8-dibenzcarbazoles was described by Boyland and Brues (1937) . 3:4:5:6-Dibenzcarbazole was found to be growth-inhibitory (Haddow and Robinson 1939) , although the effect was obscured by the marked toxicity of this compound. 1 :2:5:6-Dibenzcarbazole has proved to be much less toxic and to have considerable inhibitory powers (table 8). The sodium salt of 1:2:5:6-dibenzcarbazole-N-sulphonic acid produced no detectable in hibition after a single dose but a significant effect following repeated dosage. In similar experiments the corresponding salt of 3 :4:5:6-dibenzcarbazole appeared to be completely inactive.
(h) Derivatives of fluoranthene Fluoranthene had already been reported as non-carcinogenic (Cook, Hieger, Kennaway and Mayneord 1932) and non-inhibitory, and negative results have now been obtained, in respect of inhibition, for four related compounds (table 9).
D ibenzfluorenes and related compounds
The inhibition of growth by chemical compounds 269 
00 00 10 © 00 00 00 oc 1940 ) had previously been found inhibitory, and an extended investigation has been made of the 5 : 10-quinone and related compounds. This quinone is also active, and activity is still retained in the corresponding leuco-disulphuric acid ester. The activity of 3 :4 :8 :9-dibenzpyrene and its quinone provides an interesting contrast with the complete inactivity of the non-carcinogenic anthanthrene (Haddow and Robinson 1939) and anthanthrone.
(j) Azo compounds and related products * In a recent investigation by Cook, Hewett, Kennaway and Kennaway (1940) the primary object was to seek for any evidence of the production of cancer of the bladder by pure chemical compounds which might throw light upon the occupational incidence of this form of cancer in chemical workers, and especially in those handling /?-naphthylamine. In this work the three azonaphthalenes were selected for test, 'as it was conceivable that one or other of these might arise by mild oxidation of samples of /?-naphthylamine containing a-naphthylamine, and thus be present in the crude base5. The compounds were administered to mice by application to the skin, by subcutaneous injection and by feeding. No tumours of the bladder were obtained, although peculiar changes in that organ were produced by 1:2'-azonaphthalene. Extensive liver changes (cholangioma, hepatoma) were found in mice treated with 2:2'-azonaphthalene and with the corresponding product of reduction and rearrangement, 2:2'-diamino-1:1'-dinaphthyl.* One sarcoma was obtained following subcutaneous injection of 1:1'-azonaphthalene in thirty mice.
Experiments to determine the inhibitory activity of the three azonaph thalenes and other compounds are summarized in table 11. Somewhat surprisingly, 1:2'-azonaphthalene proved strongly inhibitory, whether given by injection in oil or by mouth in the form of a 10 % dispersion. Activity was retained in the 4-hydroxy and 4-amino derivatives, but not in the case of 4-acetylamino-l :2'-azonaphthalene. The toxicity of 1:2'-azonaphthalene was low, and the test animals remained in ex ceptionally good condition. Significant but lower activity was shown * 2 :2 /-D ia m in o -l: 1'-d in a p h th y l hydrochloride was recently described as exerting strong local anaesthetic action (Supniewski a n d G ajew ska 1939): a dilution of 1:2000 was sufficient to cause com plete anaesthesia of th e ra b b it cornea and th e frog skin. 
S 5 2 I I I by 1:1'-azonaphthalene, and no activity by 2 :2'-azonaphthalene. An identical relation was found for the products of reduction and rearrange ment of 1:2'-and 2:2'-azonaphthalene.* The negative results obtained for o-aminoazotoluene and p-dimethylaminoazobenzene ('butter yellow5) are of interest since these isomeric compounds produce cholangioma and hepatoma in rats (Sasaki and Yoshida 1935, Kinosita 1937) as does 2 :2'-azonaphthalene in mice.
It was earlier believed that neither o-aminoazotoluene (Nakahara and Fujiwara 1937) nor p-dimethylaminoazobenzene (Nakahara and Fujiwara 1938) produces tumours locally by injection, and Nakahara and Takahashi (1940) found these compounds to have no growth-inhibitory effect when administered to young rats, although benzpyrene and methylcholanthrene produced such an effect, perceptible but slight. However, more recently Law (1941) reported the induction of fibrosarcomas (35 in 109 mice of the C 57 black strain) following injection of o-aminoazotoluene (4'-amino-2 :3'-azotoluene), p-dimethylaminoazobenzene, 4'-hydroxy-2 :3'-azotoluene and 2:3'-azotoluene; only one sarcoma appeared in 106 mice of the Dba strain similarly treated, this in the ^-dimethylaminoazobenzene series. White (1940) also described a retardation of growth, in young rats, pro duced by p-dimethylaminoazobenzene administered as an addition to a basal diet of relatively low protein content.
In additional experiments on twenty water-soluble azo dyes (table 12) , only two instances of significant inhibition were observed. In one case (experiments 123, 124) the effect was not reproduced by a smaller dose, and the other is noteworthy (experiment 118), since the compound is much less soluble than others in the series, and is insoluble in the cold. Cook et al. (1940) reported a number of experiments to determine the carcinogenic activity of certain water-soluble azo-dyes (including that tested in experi ment 102 of the present series): in their experiments 'not a single tumour appeared that could be attributed to the colouring matters, and such a result is in accord with the view that rapid elimination of these water-soluble sodium sulphonates would tend to prevent their exerting a carcinogenic influence5.
* B y analogy w ith th e rearran g em en t of 1: l'-h y d razo n ap h th alen e, 
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The inhibition of growth by chemical compounds Table 13 presents experiments with compounds in which two naphtha lene moieties are united by different types of linkage, viz. -NH-, -CH=N-, -CH2-NH-, -NH-C=N-, -S0 2-NH-, -S0 2-N-, CN and -S-S-. These results are of importance as indicating that certain characters are probably essential in the nature of the bridge between two naphthalene nuclei, if such compounds are to show the inhibitory activity possessed by 1:1'-and 1:2'-azonaphthalene. Significant activity was recorded for 1:1'-and 1:2'-naphthalene-sulphon-naphthylamide but not for the 2:2' compound, a relationship similar to that obtaining in the azonaphthalenes. It is of considerable additional interest however that the 2:1' isomeride appeared inactive. No data are as yet available for the carcinogenic activity of these compounds, except in the case of oca-and /?/?-dmaphthylamine, which Boyland and Brues (1937) reported as inactive.
(k) Compounds exhibiting varied linkage
(l) Ndphihylamines; naphthaquinone Various considerations led to tests of /?-naphthylamine and water-soluble sulphonates, naphthylamine sulphonamides, and analogues of vitamin K. No inhibitory activity was noted for any of these compounds in the present experiments (table 14) , with the possible exception of one experiment (not reported) in which rats received 2-naphthylamine-4 :8-disulphonic acid (in several doses of 100 mg. by intraperitoneal injection) and in which a profound interference with body growth was observed. This was later found to be secondary to an acute atrophic change in the liver, which slowly recovered by normal regeneration. As a side-action, general anaesthesia, followed by complete recovery, was noted after the intraperitoneal injec tion of /?-naphthylamine and acetyl /?-naphthylamine in 25 mg. doses. The effect was not observed with other compounds in the present work, but is probably similar to the anaesthetic action of various steroids recently described by Selye (1941) . (Compare also the local anaesthetic action of the hydrochloride of 2 :2'-diamino-l: 1'-dinaphthyl, p. 271, footnote.) (m) Arsenonaphthalenes and other arsenical compounds The positive results obtained for 1:1'-and 1:2'-azonaphthalene sug gested the examination of the three arsenonaphthalenes, as well as organic arsenicals having structural similarity to the polycyclic aromatic hydro carbons. Only preliminary experiments have been carried out thus far (table 15) . 1:1'-and 2:2'-arsenonaphthalenes were administered in a single The inhibition of growth by chemical compounds 279 I f PS vO PS vO © X dose approaching the maximum tolerated. In two experiments with these compounds (159, 161) no inhibition was observed, although a striking effect was noted in a large reduction of food intake. In experiments 160 and 162, on the other hand, the same doses produced manifest toxic effects (possibly on account of the fact that the compounds were less completely dissolved): in this case it is felt that the recorded inhibition had no real importance. It is desirable to test the activity of 1:2'-arsenonaphthalene, and this work is being continued.
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(n) Derivatives of triphenylethylene
Following the statement of Zondek (1936a) that prolonged treatment with folliculin produces considerable retardation of body growth, numerous papers have testified to the capacity of oestrogenic substances, both naturally occurring and synthetic, to inhibit growth (see discussion). Table 16 presents the results obtained in tests with six derivatives of triphenylethylene, the oestrogenic activity of which was described by Robson and Schonberg (1937) . These compounds are possibly of special significance since they, with triphenylethylene itself, may be formulated to indicate relationship to a meso-(and 4-) substituted benzanthracene with two rings disrupted. In certain of these experiments an inhibitory effect on body growth was detectable, and at autopsy the regressive change in the testis, which is well recognized as a result of oestrogen action, was also apparent. Table 16 includes the relevant data from experiment 170. In this case the evidence for inhibition of body growth is only presumptive (although reasonable since the batches were carefully balanced), as the weights of the rats at the beginning of the experiment were not recorded.
(o) Diphenyl derivatives of indene, fl-naphthindole and /3 -naphthofuran
Tests with four derivatives of indene, /?-naphthindole and /?-naphthofuran, which possess a certain degree of relationship to stilbene and tri phenylethylene, and are with one exception oestrogenic, are given in table 17. Inhibition to a significant extent was observed for 1:2-diphenylindene only.
(
p) Cholic acid; deoxycholic acid
Negative results were obtained with deoxycholic and cholic acids (3 : 12-dihydroxy and 3 :7 : 12-trihydroxy cholanic acid respectively) (table 18). Although deoxycholic acid is an important constituent of normal bile, injection of the compound has recently been shown (Cook, Kennaway and Kennaway 1940; confirming Ghiron 1939) to result in the 
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The inhibition of growth by chemical compounds 283 production of sarcoma, both in stock mice (4 sarc./10 mice/422 days) and mice of the C3H strain (7 sarc./10 mice/207 days); only one epithelioma appeared on repeated and prolonged application of the acid to the skin (in 100 mice). Dehydrogenation of dehydronorcholene (non-inhibitory, Haddow and Robinson 1937), which may be obtained from deoxycholic acid by the procedure of Wieland, yields the benzanthracene hydrocarbon methylcholanthrene (Wieland and Dane 1933 ; Cook and Haslewood 1933) ; again, Fieser and Newman (1935) showed that methylcholanthrene could also be obtained from cholic acid. It will therefore be important to deter mine, if possible, whether deoxycholic acid possesses intrinsic carcinogenic activity, or is subject to a transformation in vivo yielding traces of an active product. In discussing this question (r) Miscellaneous compounds Of the miscellaneous group of compounds in table 20, attention may be drawn to those giving indications of significant inhibitory activity: 5 -amino -1 :2 -benzanthracene, 4 -methylbenzanthrone, benzanthrone -4 -aldehyde, di-a-naphthyl ether and 1: l'-dinaphthylene-2:2'-oxide. Among these compounds, 5-amino-1 :2-benzanthracene is under test for carcino genicity, and has produced one spindle-cell sarcoma (day 206).
Of compounds yielding negative results 3(N)-4-pyridinopyrene (Vollmann, Becker, Corell and Streeck 1937), a nitrogenous analogue of 3 :4-benzpyrene, has proved non-carcinogenic (0 pap., 0 epith./19 mice/748 days, Badger et al. 1940). 1: l'-Dinaphtho-2:2'-orthodiazine was tested following the results obtained with the azonaphthalenes, although it is more nearly analogous to the non-carcinogenic 3 :4 :5 :6-dibenzphenanthrene : in a continuation of these experiments it is hoped to examine 2:2'-dinaphtho-l: l'-orthodiazine and 1:2'-dinaphtho-2: l'-orthodiazine, which may be regarded as similarly related to 1 :2:7 :8-dibenzphenanthrene (picene) and 1 :2 :5 :6-dibenzphenanthrene, respectively. Strong (1938 Strong ( , 1939 showed that the growth of spontaneous mammary tumours in mice is inhibited by the oral administration of heptaldehyde. This observation was confirmed by Boyland and Mawson (1938; see also Boyland 1940) , who showed in addition that citral had a greater inhibitory effect. The results in the present tests show no effect on the 15th day following a single intraperitoneal injection in oil, but a strong inhibitory effect was obvious by inspection at an earlier stage (8-10 days), passing off with some rapidity in the last few days of the experiment.
D iscussion (a)
Correlation of inhibitory activity and carcinogenicity (i) The carcinogenic hydrocarbons and related compounds.
It has already been stated that doses employed in these experiments were in most cases only 50 % of those in earlier work, since the main object was the selection of more active compounds. That a single dose of c. 25 mg./ 100 g. is probably insufficient to produce a demonstrable effect in the case of weaker compounds is suggested by figure 1: although all seven of the 5-alkyl benzanthracenes tested produce epitheliomata, statistically signi ficant inhibition was detected only in four members, which included the first three of the series. Yet the values taken together indicate a general trend, and it is justifiable to conclude that increase in size of the sub stituent is accompanied by a decline both in inhibitory activity and the power to induce epithelioma in mice. The correspondence is possibly even closer when carcinogenicity is measured by the capacity to evoke sarco mata. These data have not been presented graphically since they are derived from different sources and are incomplete (for the 5-ethyl and 5-w-propyl members). However, figures given by Fieser (1938) show a carcinogenic index of 46 for 5-methyl-1 :2-benzanthracene when tested in strain A mice, and the value is zero for the 5-w-butyl, -/i-amyl, -w-hexyl and -w-heptyl derivatives in stock mice (Badger et al. 1940) .
A similar relation probably holds for the 10-alkyl benzanthracenes? although the rate of decline is steeper: thus while 10-methyl-1:2-benzan thracene is actively carcinogenic and inhibitory, neither activity is present in the 10-isopropyl compound. Data on the sarcoma-producing capacity of 10-substituted benzanthracenes in strain A mice are also provided by Fieser (1938) . On the basis of these figures the carcinogenic index for 10-methyl 
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A striking degree of correspondence is often shown by the properties of closely related compounds. Thus while the carcinogenic hydrocarbon 1 :2 :5 :6-dibenzfluorene is strongly inhibitory, 3 :4 :5 :6-dibenzfluorene is inactive in both respects. Again, 1 :2 :3 :4-tetramethylphenanthrene appears non-inhibitory, but 1:2-dimethylchrysene and 1:2:3:4-dibenzphenanthrene exhibit pronounced inhibitory and carcinogenic properties. However, although exceptionally lowr dosage must be taken into account, no inhibition was demonstrated for 10-/?-hydroxyethyl-, 10-acetoxymethyl-, 9 : 10-bishydroxymethyl-, 9 : 10-bisacetoxymethyl-or 9-methyl-10-cyano-l: 2-benzanthracene, all of which are carcinogenic.
In the course of these investigations it has become apparent that carcino genicity is not an absolute property but one influenced in its manifestation by the varied sensitivity of different tissues, strains and species. Other factors may operate in particular cases, including the possibility that certain compounds, inactive of themselves, may undergo transformation to an active compound in vivo (e.g. vide 2:2'-azonaphthalene infra). This has already been considered for deoxycholic acid, and it had previously been suggested by that the slight carcinogenic activity of cer tain dihydro compounds might be related to their dehydrogenation to the aromatic structure. It is obvious that were such transformation to occur slowly, no evidence of inhibition would be obtained in a short experiment.
In addition to instances in which compounds have proved carcinogenic although no inhibitory effect has been detected, examples have been encountered of compounds possessing inhibitory activity but appearing non-carcinogenic. Three such compounds, previously reported, later proved to be carcinogenic, in experiments finally reported by Badger et al. (1940) , and a proportion of the exceptions in this category may be accounted for in the same manner: £ The experiments of Haddow and Robinson... on the correlation between growth-inhibitory action and carcinogenic activity of polycyclic compounds had shown that the 3-and 7-methyl derivatives of 1:2-benzanthracene were anomalous inasmuch as they produced strong inhibition of growth, although our earlier tests had not given tumours when the compounds were applied to the skin of mice. The experiments now reported on the marked sarcoma-producing power of these two hydro carbons remove this discrepancy. Similar considerations apply in the case of " acenaphthanthracene" ; this hydrocarbon, which also gave negative results in earlier tests for carcinogenic action, showed marked inhibition of tumour growth. In more extensive tests the compound has given ten tumours. . .on application to the skin of fifty mice, and has also given sarcomas in six out of ten mice into which it was injected subcutaneously.'
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Even when full allowance has been made for cases explicable as described, there still remains a number of compounds which are strongly inhibitory but yield few or no tumours in exhaustive tests. An outstanding member of this class appears to be 1:2'-azonaphthalene. In addition there must be considered a group of growth-inhibitory oestrogenic substances which, although not carcinogenic in the usual sense, nevertheless are clearly associated with the induction of individual types of tumour under special conditions. These classes are of sufficient importance to warrant separate discussion. Meanw'hile attention can be drawn to two conditions in which a substance, not demonstrably carcinogenic, may show' inhibitory pro perties similar to those of the carcinogenic compounds, viz.:
(1) if the cells become continuously adapted to its action, without discontinuous change involving an alteration of growth rate, and (2) if for an unknown reason the induction of a discontinuous adaptation is difficult or impossible.
In illustration of the first postulate may be mentioned the description by Selye (1940) of cellular adaptation to oestrogen overdosage (acquired hormone resistance). The second finds an accurate parallel in the varying facility with which different trypanocides induce the formation of drugresistant protozoal strains.
(ii) Azonaphthalenes.
At the moment, interpretation of the results obtained with the azonaph thalenes is difficult, and the most marked contrast is presented by the behaviour of the 1:2' and 2:2' compounds. Cook et al. (1940) pointed out that azo substances may be reduced in the body to amines by way of the hydrazo compound. When liver changes were found in mice treated with 2:2'-azonaphthalene, the fact that the hydrazonaphthalenes are susceptible to a benzidine type of rearrangement led these workers to make tests with the compound which might thus be formed, viz. 2:2'-diamino-1:1'-dinaphthyl. This compound induced liver changes wdth even greater facility than 2:2'-azonaphthalene, and the result was specially significant in view of the ease with which the diamino-dinaphthyl undergoes deamina tion to 3 :4 :5 :6-dibenzcarbazole, which Boyland and Brues (1937) had already shown to be capable of producing liver tumours, epithelioma and sarcoma in mice. The relations between these compounds, with their inhibitory and carcinogenic activity, are shown in table 21.
Taken alone, these relations form a consistent scheme, compatible with and even supporting the suggestion that 2:2'-azonaphthalene is not inherently carcinogenic but acts by a transformation to 3 :4 :5 : 6-dibenz- carbazole. Conversion in the liver might account for the localization of tumour production to that organ, and the fact that the intermediate diamine is even more potent than the azo compound is also consistent. However, no facts are as yet available regarding the changes undergone by 2:2'-azonaphthalene in vivo, although experiments are being carried out in this Institute by Mr F. L. Warren and will be reported later. Interest in the relation between carcinogenic and oestrogenic activity was stimulated by the work of Cook and Dodds (1933) and Cook, Dodds, Hewett and Lawson (1934) . These authors found a degree of oestrogenic activity in the carcinogenic hydrocarbons 5 :6-c«/cZopenteno-l ^-benzan thracene and 3 :4-benzpyrene, and proceeded to examine compounds containing the same ring system as the carcinogenic hydrocarbons, but with polar groups present and with some rings reduced. 1 :2 :5 :6-Dibenz anthracene itself proved non-oestrogenic, but high activity was shown by the 9 :10-diethyl, di-n-propyl and di-w,-butyl derivatives of 1:2:5 :6-dibenz-9 :10-dihydroanthraquinol, maximal potency being obtained with the di-w-propyl compound. This substance was later found by Haddow and Robinson (1937) to be strongly inhibitory, and still later reported as having produced a few sarcomata in rats (Bachmann and Bradbury 1937) .
The work of Cook and Dodds subsequently led to a considerable in vestigation of the relations between molecular structure and oestrogenic activity, special attention being paid to various hydrocarbon derivatives of ethylene (Dodds and Lawson 1938) . Of the oestrogenic compounds examined for growth-inhibitory activity in the present work, the active analogues of triphenylethylene are of special interest as possessing a remote degree of similarity to a meso-substituted benzanthracene. Reports by various workers of growth-inhibitory effects produced by diethylstilboestrol (vide infra) suggested an extension of the present investigation by an examination of certain naphthalene and other analogues of stilbene and its derivatives, as well as similarly substituted ethanes and acetylenes, of the general types: 
R2 A r±-CH-CH-A r2
Rx R2 (Arx = phenyl, a-naphthyl, /?-naphthyl. Ar2 = a-naphthyl. Rv R2 = Me, Et.)* For several of the proposed ethylene structures the relationship to known inhibitory polycyclic hydrocarbons (e.g. 1:2:5 :6-dibenzanthracene, 1 :2 :5 :6-dibenzfluorene) is much closer than for the triphenylethylene derivatives already tested. These experiments are not sufficiently advanced to permit any conclusions to be drawn: it may be mentioned, however, that little or no inhibitory activity has been detected for 2:2'-and 1:2'-dinaphthyl ethylene.
It has been widely accepted that oestrogens are to be regarded as growthpromoting agents (e.g. Allen 1935; Doisy 1941) . There is certainly ample evidence for this belief, and much more than obtains in the case of the carcinogenic hydrocarbons. But evidence is also accumulating to show that oestrogens are capable of marked inhibitory effects, in many cases of the same nature as those produced by carcinogenic polycyclic hydro carbons. The oestrogens thus provide a second example of an apparently paradoxical relation, in that compounds possessing growth-inhibitory properties may also be associated with physiological stimulation of growth and with the induction of tumours in special cases.
The older literature contains several references suggesting retardation of growth by oestrogens. More recently Zondek (1936a) described inhibition of body growth by administration of oestrin, and similar results were 292 G. M. Badger et at.
reported by Noble (1939a) and Gaarenstroom and Levie (1939) in the case of diethylstilboestrol. These effects appear similar to the retardation of body growth produced by intraperitoneal injection of many carcinogenic hydrocarbons (Haddow et al. 1937) .
Many other papers have reported a more specific inhibitory effect of oestrogens, viz. the production of sterility, azoospermia or testicular atrophy (e.g. Burrows and Kennaway 1934; Lacassagne 1934; Pincus and Kirsch 1936) . This phenomenon also finds a parallel in the action of many carcinogenic hydrocarbons (Haddow' and Robinson 1937) : 'apart from their action on body growth and tumour growth the carcinogenic hydro carbons produced other effects which are no doubt correlated... .The fertility of the treated animals was very definitely lowered, and in many cases the ovary showed suppression of ovulation and the testis a variable reduction of spermatogenesis....' The extent of this effect, whether produced by carcinogens or oestrogens, can readily be estimated from the testis weights in treated animals as compared with controls.
Other effects more recently described are the induction of benignancy in the mouse sarcoma 180 (Salter, Nathanson and Wilson 1941) , and the inhibition of hair growth (Gardner and De Vita 1940) and of mammary growth (Gardner 1941) by large amounts of oestrogen.
Such results are of significance in their bearing on the theory of carcino genesis by cellular inhibition. The induction of tumours by oestrogens is most easily elicited in tissues which are highly responsive to the physio logical action of these compounds. The largest number of reports deals with the production of mammary cancer* in mice of susceptible strains, and recent papers record this effect as produced by the synthetic oestrogens diethylstilboestrol (Lacassagne 1938; Shimkin and Grady 1940) and triphenylethylene (Robson and Bonser 1938) .
Since the testis is markedly sensitive to the inhibitory action of oestro gens, the production of testicular tumours and hypertrophy of the inter stitial cells, in the testes of mice receiving oestrogens, is of special signi ficance (Gardner 1937; Hooker, Gardner and Pfeiffer 1940) . Bonser and Robson (1940) the testes showed no gross diminution in size, but interstitial hyperplasia, proceeding to nodule formation which in advanced stages appeared to be malignant, occurred in a large proportion of cases.
While the carcinogenic activity of oestrogens is influenced by their physiological specificity, sarcoma production has also been reported (Gardner, Smith, Strong and Allen 1936 a, 6; Suntzeff, Burns, Moskop and Loeb 1936; Lacassagne 1937 Lacassagne , 1939 Bachmann and Bradbury 1937) . In painting experiments by Bachmann et al. (1937) no tumours were obtained with the dibenzanthracene diols, oestrone, oestriol or other compounds related to the sterols and oestrogenic hormones. These authors emphasized that such negative results merely record a failure to induce tumours of the skin, and have no bearing on the association of oestrogenic substances with other forms of cancer: 'obviously a compound which can produce cancer is entitled to be termed carcinogenic without any qualifying restric tion as to the manner in which this is achieved.5 Negative results by painting and injection were also reported for triphenylethylene (Badger et al. 1940 ).
(b) Structural requirements for inhibitory and carcinogenic activity
The relation between molecular structure and biological activity is still insufficiently known to allow accurate prediction in individual cases. But inhibitory power is generally dependent (1) on an optimal degree of mole cular complexity, and (2) on certain more specific requirements. These conditions are best exemplified by the activity of five of the fifteen possible hydrocarbons containing systems of five condensed benzene rings (1:2:5 :6-and 1 :2 :7 :8-dibenzanthracene, 1:2 :3 :4-and 1 :2 :5 :6-dibenzphenanthrene, 3 :4-benzpyrene), and by closely related derivatives of 1:2-benz anthracene, chrysene and 3 :4-benzphenanthrene. Limited molecular simplification may be carried out without loss of activity (e.g. 5-, 9-or 10-methyl-l: 2-benzanthracene) and may proceed to a considerable extent (e.g. 1 :2 :3 :4-tetramethylphenanthrene, 9 : 10-dimethylanthracene) with out complete loss of carcinogenicity. Further, the results obtained with derivatives of triphenylethylene suggest that inhibitory activity may still be shown by compounds diverging widely from the polycyclic structure and possessing only a skeletal resemblance.* Retention of activity with * D odds, Law son a n d W illiam s (1941) have recently observed tw o spindle-celled skin tum ours in fifty stock m ice p a in te d tw ice w eekly for over 12 m onths w ith a 0*3 % solution of a-ethyl-/?-sec-butylstilbene in benzene. This com pound presents a fairly close relationship to 3 : 4-benzpyrene, a n d is w eakly oestrogenic (personal com m unication from Professor E .C . D odds 1941). increased complexity is exemplified by 3 :4 :8 :9-dibenzpyrene. Restriction may, however, be narrow, since it had previously been found that an enormous loss of inhibitory activity occurs in passing from 5:9:10-trimethyl-1 : 2-benzanthracene to the 5 :6 :9 : 10-tetramethyl derivative.
So far as inhibitory activity is concerned in derivatives of 1:2-benzan thracene and its analogues, the reactive ring of the anthracene system may be replaced, without loss of activity, by a five-membered ring, a fivemembered ring containing nitrogen, a six-membered ring containing one nitrogen atom, or a six-membered ring containing nitrogen and sulphur. Also, the effects of methyl substitution in 1:2-benzanthracene, l:2-benzacridine and 1:2-and 3 :4-benzphenothiazine appear to follow a similar law. In view of the above, the pronounced activity of 1:1'-and 1:2'-azonaphthalene is of special interest, as is also that shown by the 1:1'-and 1:2'-(but not 2:1'-) naphthalene-sulphon-naphthylamides.
Diminution of inhibitory effect with increased substituent size is shown in the 5-alkyl benzanthracenes, although the same relation does not necessarily obtain for other positions. The influence of the nature of the substituent is seen in the contrast between 10-methyl-, 10-amino-and 10-cyano-l: 2-benzanthracene (inhibitory) and 10-isopropyl-1:2-benz anthracene (inactive).
Numerous experiments have shown that solubilization of an active com pound usually entails decrease or loss of activity, although certain excep tions have been encountered.
(c) Mode of production of inhibitory effects It had already been suggested that the inhibitory effect is independent of non-specific toxicity, and the present experiments provide further support for this view. As an example, although 2 :2'-diamino-l: l'-dinaphthyl proved to be markedly toxic in experiment 94, no evidence of inhibi tion was detected; nevertheless 1:2'-azonaphthalene (experiments [96] [97] [98] produced considerable inhibition, with no manifestations of toxic action in the doses used. On the other hand, a few compounds (e.g. 1 :1'-and 2 :2'-arsenonaphthalene in experiments 160 and 162) produced a degree of inhibition which was discounted because of obvious chronic toxicity.
It is an important question whether the inhibitory property is exerted directly, or indirectly, by alterations in the anterior lobe of the pituitary gland. In a former paper (Haddow and Robinson 1937) it was concluded that ' at least a part of the general inhibition of growth produced by the carcinogenic hydrocarbons may be explicable on the basis suggested by basal diet containing the methylcholanthrene or benzpyrene resulted in a prompt stimulation of the growth rate, and the same result followed subcutaneous injection of glutathione in animals ingesting the methylcholanthrene-containing diet; on the other hand, inorganic sulphur (sodium sulphate), amino-acid nitrogen (glycine), or sulphur in the form of taurine were incapable of stimulating growth under the experimental conditions. A similar relation was observed when inhibition was produced by administration of pyrene or (White 1940) of ^-dimethylaminoazobenzene. While putting forward the above conclusion, on the basis of their own results and the data already available in the literature, White and White nevertheless emphasized the desirability of actual isolation of the mercapturic acids of these compounds, in order to place beyond doubt a relationship of growth effects to sulphur metabolism; and they also admitted the possibility that the growth-inhibitory results might not in all cases be related to a specific detoxication mechanism involving the sulphur-containing amino acids, but that some of the compounds might retard cellular metabolism.* With regard to the mechanism of direct inhibitory action by carcinogenic compounds, some attention has also been paid to the principle discovered by Fildes (1940) and Mcllwain (1940 Mcllwain ( a, 6, 1941 in the case of anti-bacterial drugs. The principle relates growth-inhibitory compounds to molecular structures of nutritional importance for the organisms concerned, and thus affords a rational basis for the modelling of chemotherapeutic agents. In the present case such an application would depend on chemical relationship between the inhibitory compound and a natural vitamin or other factor essential to the growth of the animal cell: no positive experimental evidence is as yet available.
